Shuta Ohara

7PUBLICATIONS
21CO-AUTHORS
Molecular targetsLiquid biopsiesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 26, 2026
Circulating Tumor DNA-Based Molecular Residual Disease in Early-Stage Non-Small-Cell Lung Cancer: Biology, Assays, and the Path Toward MRD-Guided Care.

|Dec 24, 2025
Current Status and Future Challenges of Liquid Biopsy.

Shuta Ohara, Kenichi Suda

|Nov 19, 2025
Low OLFM1 and BMP6 Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance.

Kenichi Suda, Yukihiro Yoshida, Hidenori Sato

|Sep 13, 2025
Efficacy of Conventional and Novel Tyrosine Kinase Inhibitors for Uncommon EGFR Mutations-An In Vitro Study.

Hana Oiki, Kenichi Suda, Akira Hamada

|Sep 13, 2025
Utility and Future Perspectives of Circulating Tumor DNA Analysis in Non-Small Cell Lung Cancer Patients in the Era of Perioperative Chemo-Immunotherapy.

Shuta Ohara, Kenichi Suda, Yasuhiro Tsutani

|Jul 27, 2024
Potential Utility of a 4th-Generation EGFR-TKI and Exploration of Resistance Mechanisms-An In Vitro Study.

Shota Fukuda, Kenichi Suda, Akira Hamada

Pageof 2

Frequent Collaborators

5 joint publications

Yasuhiro Tsutani

4 joint publications

Kenichi Suda

2 joint publications

Shota Fukuda

2 joint publications

Junichi Soh